日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Modeling the novel SERD elacestrant in cultured fulvestrant-refractory HR-positive breast circulating tumor cells

在培养的氟维司群耐药性 HR 阳性乳腺循环肿瘤细胞中模拟新型 SERD 受体拮抗剂

Taronish D Dubash #, Aditya Bardia #, Brian Chirn, Brittany A Reeves, Joseph A LiCausi, Risa Burr, Ben S Wittner, Sumit Rai, Hitisha Patel, Teeru Bihani, Heike Arlt, Francois-Clement Bidard, Virginia G Kaklamani, Philippe Aftimos, Javier Cortés, Simona Scartoni, Alessio Fiascarelli, Monica Binaschi,

Elacestrant demonstrates strong anti-estrogenic activity in PDX models of estrogen-receptor positive endocrine-resistant and fulvestrant-resistant breast cancer

Elacestrant 在雌激素受体阳性的内分泌耐药和氟维司群耐药乳腺癌的 PDX 模型中表现出强大的抗雌激素活性

Sunil Pancholi, Nikiana Simigdala, Ricardo Ribas, Eugene Schuster, Mariana Ferreira Leal, Joanna Nikitorowicz-Buniak, Camilla Rega, Teeru Bihani, Hitisha Patel, Stephen R Johnston, Mitch Dowsett, Lesley-Ann Martin

SERMs attenuate estrogen-induced malignant transformation of human mammary epithelial cells by upregulating detoxification of oxidative metabolites

SERM 通过上调氧化代谢物的解毒作用来减弱雌激素诱导的人类乳腺上皮细胞恶性转化

L P Madhubhani P Hemachandra, Hitisha Patel, R Esala P Chandrasena, Jaewoo Choi, Sujeewa C Piyankarage, Shuai Wang, Yijin Wang, Emily N Thayer, Robert A Scism, Bradley T Michalsen, Rui Xiong, Marton I Siklos, Judy L Bolton, Gregory R J Thatcher